From: APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC
Characteristic | The number of patients, n (%) |
---|---|
Age | 57.97 ± 8.36 |
Age range | |
≥ 60 years | 52 (48.15) |
< 60 years | 56 (51.85) |
Sex | |
Male | 54 (50.00) |
Female | 54 (50.00) |
Smoking status | |
ever | 49 (45.37) |
never | 59 (54.63) |
Histological cell type | |
Adenocarcinoma | 108 (100.00) |
Tumor stage | |
I | 107 (99.07) |
II | 1 (0.93) |